...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >ANTICANCER AND ANTI-METASTATIC ACTIVITIES OF RHEUM EMODI RHIZOME CHLOROFORM EXTRACTS
【24h】

ANTICANCER AND ANTI-METASTATIC ACTIVITIES OF RHEUM EMODI RHIZOME CHLOROFORM EXTRACTS

机译:鹰嘴豆泥根状氯仿提取物的​​抗癌和抗转移活性

获取原文

摘要

In spite of advancements in cancer treatments, there is still a need for effective drugs against metastatic stages of breast cancer. Rheum emodi, a well known medicinal plant is not however extensively studied for its specific anticancer and anti-metastatic potentials. The present study evaluates the hot (CHR) and cold (CCR) chloroform extracts of R. emodi for its antioxidant properties through DPPH and reducing power assay, cytotoxicity in MDA-MB-231 and WRL-68 cells, and apoptosis inductivity in MDA-MB-231 and MCF-7 cells. Further, the anti-metastatic potential of CHR was also analysed by cell migration inhibition in MDA-MB-231 cells which is reported for the first time in this study. Both CHR and CCR exhibited efficient antioxidant properties, and significant cytotoxicit y and apoptosis induction abilities. CHR had an exceptional ability to inhibit the migration of MDA-MB-231 cells. The extracts were then characterized semi-quantitatively and quantitatively to reveal its phytochemicals subsequent to HPLC analysis. Both CHR and CCR have demonstrated affirmative anticancer abilities with CHR also possessing capability to inhibit metastasis. Thus chloroform extracts of R. emodi could be considered in designing effective anticancer drugs especially against metastatic stages of breast cancer
机译:尽管癌症治疗方面取得了进步,但是仍然需要针对乳腺癌转移阶段的有效药物。然而,由于其特异的抗癌和抗转移潜力,著名的药用植物大黄大黄未得到广泛研究。本研究通过DPPH和降低功率分析,MDA-MB-231和WRL-68细胞的细胞毒性以及MDA-MB的凋亡诱导性,评估了红景天的热(CHR)和冷(CCR)氯仿提取物的​​抗氧化性能。 MB-231和MCF-7电池。此外,还通过在MDA-MB-231细胞中的细胞迁移抑制分析了CHR的抗转移潜力,这在本研究中首次报道。 CHR和CCR均显示出有效的抗氧化剂特性,并具有显着的细胞毒性和凋亡诱导能力。 CHR具有抑制MDA-MB-231细胞迁移的出色能力。然后对提取物进行半定量和定量表征,以在HPLC分析后显示其植物化学成分。 CHR和CCR均显示出肯定的抗癌能力,CHR也具有抑制转移的能力。因此,在设计有效的抗癌药物,尤其是针对乳腺癌转移阶段的抗癌药物时,可以考虑使用R. emodi的氯仿提取物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号